tykhr
sign in
free sign up
Entasis Therapeutics Holdings Inc
Biotechnology
Healthcare
ETTX
47.31 M shares
NASDAQ US
traded
08 Jul 2022
listed
yes
open
2.19
52 week high
3.77
high
2.20
52 week low
1.45
low
2.19
growth
-10.25 %
previous Close
2.20
P/E ratio
market cap
89.96 M
div yield
0
usd
Mar 2022
qoq
revenue
0.00 %
net incoming
0.00 %
eps
-28.00 %
eps surprise
-23.08 %
net profit margin
0.00 %
0.00 %
operating incoming
-15.93 M
69.55 %
net change in cash
1.24 M
110.49 %
cash on hand
33.55 M
3.84 %
cost of revenue
0.00 %
top